The seed and fertliliser producer, which counts Monsanto as an investor, has set the range for an initial public offering that could net up to $142m.
Bioceres, an Argentina-based crop improvement technology provider that counts agribusiness Monsanto as an investor, has set the range for an initial public offering in the US that could raise up to $142m.
The offering is set to consist of approximately 11.8 million American depositary shares issued on the New York Stock Exchange, priced between $10 and $12.
Bioceres produces seeds, seed traits and treatments as well as biological products and fertilisers. It made a $5.2m net loss in 2016 from…
